BEGIN:VCALENDAR
VERSION:2.0
X-WR-CALNAME;VALUE=TEXT:FDA's Impact of Pharmaceutical Innovation:  A lecture by Neil Flanzraich
PRODID:-//Harvard events data//EN
BEGIN:VEVENT
UID:event_394676_0
SUMMARY:FDA's Impact of Pharmaceutical Innovation:  A lecture by Neil Flanzraich
DESCRIPTION:<p>Program of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics</p><p><strong>Guest speaker:</strong><br><em><strong>Neil Flanzraich</strong></em></p><p>Please join us for a lecture by Neil Flanzraich, Chairman and CEO of Cantex Pharmaceuticals, Inc., discussing the balance between speed and safety in FDA’s regulation of pharmaceutical products. Topics will include how FDA’s approach has ebbed and flowed over time, the various tools FDA has introduced to reach this balance, and the potential impact of FDA’s various approaches on products and companies, especially start-ups.</p><p>Neil Flanzraich graduated from Harvard Law School in 1968 and was appointed by Dean Martha Minow as an Expert in Residence at the Harvard Innovation Lab (i-lab) in fall 2012.</p><p>This event is free and open to the public. Lunch will be provided.</p>
LOCATION:Harvard Law School, Griswold Hall, Room 110, 1525 Massachusetts Avenue, Cambridge, MA
STATUS:CONFIRMED
DTSTART:20150414T160000Z
DTEND:20150414T170000Z
END:VEVENT
END:VCALENDAR